Developer of human gene-based therapies. The company has developed a platform to bring new disease-modifying therapies to patients with severe disorders. The company's pipeline includes gene-based therapies for lipoprotein lipase deficiency, or LPLD, Sanfilippo B, Parkinson's Disease and Hemophilia B.read more
Maria Cantor ā Senior Vice President Investor Relations and Communications at uniQure
Executive Bio
Maria Cantor serves as the Senior Vice President Investor Relations and Communications of uniQure. Maria started at uniQure in June of 2016. Maria currently resides in the Greater Boston Area.
Executive Team Culture Ratings from uniQure Employees
TOP
10%
uniQure's Executive Team scores in the Top 10% of similar sized companies on Comparably